πŸ“ˆ Jumpstart Signal Watchlist β€” May 29, 2026

πŸš€ Growth ($5-$20)

# Ticker Signal Industry Score (100) Q+E+S+B Price Change RSI 3yr High
1 MITK πŸ“Œ MONITOR Computer Peripheral Equipment 53 (31+2+10+10) $17.18 +1.4% 68 $17.19
2 MGTX πŸ“Œ MONITOR Biological Products 50 (23+7+10+10) $10.65 +6.2% 65 $11.29
3 LOCO πŸ“Œ MONITOR Restaurants 50 (35+5+10+0) $14.87 +1.2% 69 $14.87
Screening Criteria ↓

βš–οΈ Momentum ($20-$100)

# Ticker Signal Industry Score (100) Q+E+S+B Price Change RSI 3yr High
1 CDNA πŸ“Œ MONITOR Medical Laboratories 59 (52+4+3+0) $22.82 +1.1% 66 $33.99
2 CENX πŸ“Œ MONITOR Primary Aluminum 56 (47+0+9+0) $65.97 -3.5% 58 $67.94
3 MCHP πŸ“Œ MONITOR Semiconductors 53 (34+0+9+10) $94.65 -2.3% 56 $102.92
Screening Criteria ↓

πŸ† SPOTLIGHT   |   βœ… OPPORTUNITY   |   πŸ“Œ MONITOR

πŸš€ Growth β€” Analysis

MITK πŸ“Œ MONITOR - Mitek Systems, Inc.
Score: 53/100 (31+2+10+10) Price: $17.18 Chg: +1.4% RSI: 68 Vol: 629K 3yr High: $17.19

🏒 What they do: Mitek Systems, Inc. (MITK) specializes in digital identity verification, authentication, biometrics, mobile image capture, and fraud detection solutions. Its enterprise-grade platform enables secure onboarding, check deposits, transaction protection, and real-time defense against threats like deepfakes and synthetic fraud for banks, fintechs, and other organizations.
- 🎯 Current $17.18 is 0% below 3yr high $17.19 Β· ⏳ SMA200 $11.53 (current price $17.18 is above) Β· πŸ’° Market Cap $771M
- MITK shows decent technicals supported by positive sentiment.

πŸ’Ž Quality (Q): 31/60
- 🏦 Low drawdown (13.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; Low LT D/E 0.21 (<1.0).
⏰ Entry (E): 2/20
- πŸ”” Strong above EMA21 (11.5%)
- πŸ”” Strong above EMA50 (17.4%)
- πŸ”” VWMA trending up (5 consecutive days)
- πŸ“ˆ RSI at 68 showing strength
πŸ“’ Sentiment (S): 10/10
- πŸ—žοΈ News sentiment is positive.
βœ… Mitek (MITK) Earnings Date & Report β€” Investing.com.
πŸ€– This article reports that Mitek’s Q2 FY2026 EPS of $0.38 beat the $0.34 forecast and revenue of $54.8 million topped the $52.59 million estimate. It also notes the stock rose 2.5% to $15.61, which is a positive sign for the shares.
🍭 Bonus (B): 10/10 β€” Computer Peripheral Equipment (Technology sector)

MGTX πŸ“Œ MONITOR - MeiraGTx Holdings plc
Score: 50/100 (23+7+10+10) Price: $10.65 Chg: +6.2% RSI: 65 Vol: 2.3M 3yr High: $11.29

🏒 What they do: MeiraGTx Holdings plc is a clinical-stage genetic medicines company that develops gene therapies and other genetic medicine platforms for both rare and more common diseases. Its work includes programs in eye diseases, Parkinson’s disease, and radiation-induced dry mouth, along with its riboswitch technology for controlled delivery of biologic therapies.
- 🎯 Current $10.65 is 6% below 3yr high $11.29 Β· ⏳ SMA200 $8.26 (current price $10.65 is above) Β· πŸ’° Market Cap $864M
- MGTX shows decent technicals supported by positive sentiment.

πŸ’Ž Quality (Q): 23/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 139% (>20%).
⏰ Entry (E): 7/20
- πŸ”” Strong above EMA21 (10.0%)
- πŸ”” Strong above EMA50 (14.9%)
- πŸ”” VWMA trending up (5 consecutive days)
- πŸ“ˆ RSI at 65 showing strength
πŸ“’ Sentiment (S): 10/10
- πŸ—žοΈ News sentiment is positive.
βœ… MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of Moderate Buy From Analysts β€” MarketBeat.
πŸ€– Analysts reiterated a constructive stance on MeiraGTx, with an average rating of Moderate Buy. The article also notes the company’s Q1 EPS beat, which supports a positive read-through for the stock.
βœ… HC Wainwright Predicts MeiraGTx's Q2 Earnings (NASDAQ:MGTX) β€” MarketBeat.
πŸ€– HC Wainwright raised its Q2 2026 loss estimate for MeiraGTx while maintaining a Buy rating, which is generally supportive for the stock. The updated forecast suggests analysts see less downside than before.
βœ… HC Wainwright Has Optimistic Outlook of MeiraGTx Q4 Earnings β€” MarketBeat.
πŸ€– HC Wainwright increased its earnings forecast for MeiraGTx, indicating a more optimistic view of near-term performance. Analyst forecast upgrades are typically a favorable signal for the shares.
🍭 Bonus (B): 10/10 β€” Biological Products (Biotech sector)

LOCO πŸ“Œ MONITOR - El Pollo Loco Holdings, Inc.
Score: 50/100 (35+5+10+0) Price: $14.87 Chg: +1.2% RSI: 69 Vol: 766K 3yr High: $14.87

🏒 What they do: El Pollo Loco is a restaurant chain that specializes in fire-grilled, citrus-marinated chicken and Mexican-inspired entrees. It operates company-owned and franchised locations, primarily in the Southwestern United States, especially Southern California.
- 🎯 At/above 3yr high $14.87 (current $14.87) Β· ⏳ SMA200 $11.38 (current price $14.87 is above) Β· πŸ’° Market Cap $453M
- LOCO shows decent technicals supported by positive sentiment.

πŸ’Ž Quality (Q): 35/60
- 🏦 Base breakout (range: 8.8%); Low drawdown (13.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 42% (>20%); Low LT D/E 0.15 (<1.0).
⏰ Entry (E): 5/20
- πŸ”” Strong above EMA21 (7.3%)
- πŸ”” Strong above EMA50 (10.4%)
- πŸ”” VWMA trending up (5 consecutive days)
- πŸ“ˆ RSI at 69 showing strength
πŸ“’ Sentiment (S): 10/10
- πŸ—žοΈ News sentiment is positive.
βœ… El Pollo Loco Q1 Earnings Call Highlights β€” MarketBeat.
πŸ€– The article highlights El Pollo Loco's Q1 results, including GAAP net income of $8.2 million, or $0.27 per diluted share, versus $5.5 million, or $0.19 per diluted share, in the prior-year period. That year-over-year improvement is generally supportive for the stock.
🍭 Bonus (B): 0/10 β€” Restaurants

βš–οΈ Momentum β€” Analysis

CDNA πŸ“Œ MONITOR - CareDx, Inc.
Score: 59/100 (52+4+3+0) Price: $22.82 Chg: +1.1% RSI: 66 Vol: 652K 3yr High: $33.99

🏒 What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- 🎯 Current $22.82 is 33% below 3yr high $33.99 Β· ⏳ SMA200 $17.60 (current price $22.82 is above) Β· πŸ’° Market Cap $1.2B
- CDNA shows favorable technicals but negative sentiment warrants caution.

πŸ’Ž Quality (Q): 52/60
- 🏦 Base breakout (range: 9.7%); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 126% (>20%); Revenue growth 39% (>15%); ROE 21% (>15%).
⏰ Entry (E): 4/20
- πŸ”” Strong above EMA21 (7.2%)
- πŸ”” Strong above EMA50 (12.1%)
- πŸ“ˆ RSI at 66 showing strength
πŸ“’ Sentiment (S): 3/10
- πŸ—žοΈ News sentiment is negative.
❌ CareDx director Arthur Torres sells $214,675 in company stock β€” Investing.com.
πŸ€– A director sale can be a mild negative signal for sentiment because it may suggest insider caution, although this transaction alone does not indicate a change in CareDx’s fundamentals.
βšͺ️ CareDx to Participate in Upcoming Investor Conferences β€” Business Wire.
πŸ€– This is a routine investor-relations announcement and does not provide new operating results, guidance, or a catalyst that would directly change the stock’s valuation.
βšͺ️ CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) β€” Business Wire.
πŸ€– The company issued inducement RSUs to new employees, which is a standard compensation-related action and is not itself a clear positive or negative operating signal for the stock.
🍭 Bonus (B): 0/10 β€” Medical Laboratories

CENX πŸ“Œ MONITOR - Century Aluminum Company
Score: 56/100 (47+0+9+0) Price: $65.97 Chg: -3.5% RSI: 58 Vol: 2.9M 3yr High: $67.94

🏒 What they do: Century Aluminum Company (CENX) is a global producer of bauxite, alumina, and primary aluminum. It operates bauxite mining and alumina refining in Jamaica (Jamalco), aluminum smelters in the United States (Hawesville and Sebree in Kentucky, Mt.
- 🎯 Current $65.97 is 3% below 3yr high $67.94 Β· ⏳ SMA200 $42.20 (current price $65.97 is above) Β· πŸ’° Market Cap $6.5B
- CENX shows decent technicals supported by positive sentiment.

πŸ’Ž Quality (Q): 47/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1014% (>20%); ROE 36% (>15%); Low LT D/E 0.22 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- πŸ”” Strong above EMA21 (5.8%)
- πŸ”” Strong above EMA50 (10.2%)
- πŸ”” VWMA trending up (5 consecutive days)
πŸ“’ Sentiment (S): 9/10
- πŸ—žοΈ News sentiment is positive.
βœ… Century Aluminum stock hits 52-week high at 68.7 USD β€” Investing.com.
πŸ€– The article says CENX reached a 52-week high of $68.70, which signals strong recent price momentum and investor demand. That kind of breakout is generally supportive for the stock in the near term.
βœ… S&P upgrades Century Aluminum rating on stronger metrics β€” Investing.com.
πŸ€– S&P’s upgrade is favorable because it reflects stronger operating metrics and the expectation of adjusted EBITDA of $700 million to $800 million in fiscal 2026. A ratings upgrade can improve investor confidence and support the stock price.
βšͺ️ Century Aluminum beats Q1 2026 forecasts, stock falls β€” Investing.com.
πŸ€– The company beat Q1 2026 expectations on both EPS and revenue, which is fundamentally positive, but the article says the stock fell anyway. Because the market reaction is mixed, the overall stock impact is best classified as neutral.
🍭 Bonus (B): 0/10 β€” Primary Aluminum

MCHP πŸ“Œ MONITOR - Microchip Technology Incorporated
Score: 53/100 (34+0+9+10) Price: $94.65 Chg: -2.3% RSI: 56 Vol: 11.4M 3yr High: $102.92

🏒 What they do: Microchip Technology Incorporated (MCHP) is an American semiconductor company that designs and manufactures microcontrollers, mixed-signal, analog, and Flash-IP integrated circuits, along with microprocessors, analog power management devices, wireless and wired communication products, and secure embedded control solutions.
- 🎯 Current $94.65 is 8% below 3yr high $102.92 Β· ⏳ SMA200 $70.59 (current price $94.65 is above) Β· πŸ’° Market Cap $51.3B
- MCHP shows decent technicals supported by positive sentiment.

πŸ’Ž Quality (Q): 34/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 176% (>20%); Revenue growth 35% (>15%); Low LT D/E 0.85 (<1.0).
⏰ Entry (E): 0/20
- πŸ”” VWMA trending up (5 consecutive days)
πŸ“’ Sentiment (S): 9/10
- πŸ—žοΈ News sentiment is positive.
βœ… Microchip Technology Announces Financial Results for Fourth Quarter and Fiscal Year 2026 β€” GlobeNewswire.
πŸ€– Microchip reported fourth-quarter fiscal 2026 net sales of $1.311 billion, up 35.1% year over year and 10.6% sequentially, which is generally supportive for the stock. The release also signals improving operating performance and gives investors fresh financial results to assess.
βœ… Microchip Technology Q4 Earnings Call Highlights - MarketBeat β€” MarketBeat.
πŸ€– The earnings call highlights show fiscal 2026 net sales of $4.713 billion, up 7.1% from fiscal 2025, with non-GAAP gross margin of 58.5% and non-GAAP EPS of $1.64. Those figures are constructive for sentiment because they indicate profitability and revenue recovery.
βšͺ️ LHM Inc. Acquires New Position in Microchip Technology Incorporated ($MCHP) β€” MarketBeat.
πŸ€– This is a holdings/ownership update rather than a business or operating update, so it has limited direct impact on Microchip's fundamentals. It may be mildly supportive as it reflects institutional interest, but it does not change the company's earnings or guidance.
🍭 Bonus (B): 10/10 β€” Semiconductors (Technology sector)

πŸ” Screening Criteria Changelog β†’

Back to top ↑

🌱 ESG/SRI Exclusions

The following categories are excluded from our screening universe (with a few whitelisted exceptions):

Back to top ↑

Get Daily Advanced Signals Free

Actionable and freshly screened US πŸ‡ΊπŸ‡Έ stocks in your inbox every trading day.

Your subscription could not be saved. Please try again.
Your subscription has been successful.